1. Home
  2. OMF vs RGEN Comparison

OMF vs RGEN Comparison

Compare OMF & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneMain Holdings Inc.

OMF

OneMain Holdings Inc.

HOLD

Current Price

$64.07

Market Cap

8.3B

Sector

Finance

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$168.96

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OMF
RGEN
Founded
1920
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
8.2B
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
OMF
RGEN
Price
$64.07
$168.96
Analyst Decision
Buy
Buy
Analyst Count
13
11
Target Price
$68.23
$177.18
AVG Volume (30 Days)
1.0M
588.4K
Earning Date
02-05-2026
02-19-2026
Dividend Yield
6.61%
N/A
EPS Growth
29.36
N/A
EPS
5.90
0.03
Revenue
$2,892,000,000.00
$707,890,000.00
Revenue This Year
$72.81
$17.86
Revenue Next Year
$8.39
$12.44
P/E Ratio
$10.77
$6,418.69
Revenue Growth
16.10
11.74
52 Week Low
$38.00
$102.97
52 Week High
$71.93
$182.52

Technical Indicators

Market Signals
Indicator
OMF
RGEN
Relative Strength Index (RSI) 39.47 58.01
Support Level $63.24 $157.29
Resistance Level $71.93 $172.51
Average True Range (ATR) 1.70 6.42
MACD -0.92 -0.42
Stochastic Oscillator 8.98 64.56

Price Performance

Historical Comparison
OMF
RGEN

About OMF OneMain Holdings Inc.

OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company's reportable segment is Consumer and Insurance. The main source of revenue is net interest income.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: